Assessment of the effectiveness of three different cephalosporins/clavulanate combinations for the phenotypic confirmation of extended spectrum beta lactamases producer bacterial isolates from urine samples at National Public Health Laboratory, Kathmandu, Nepal

BMC Research Notes

Volumn 9, Issue 1, 2016, Pages

  Pant, Narayan Dutt ^a   Bhandari, Raju ^b   Poudel, Asia ^b   Sharma, Mukunda ^c  

^a GRANDE INTERNATIONAL HOSPITAL   (Nepal)

^b Department of Environmental Science GoldenGate International College   (Nepal)

^c National Public Health Laboratory   (Nepal)

Author keywords

Antibiotic susceptibility patterns; Extended spectrum beta lactamases; Nepal; Uropathogens

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID;

BACTERIUM; CLINICAL LABORATORY SERVICE; COMBINATION DRUG THERAPY; ENZYMOLOGY; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEPAL; PHENOTYPE; PUBLIC HEALTH; REPRODUCIBILITY; TREATMENT OUTCOME; URINE;

ANTI-BACTERIAL AGENTS; BACTERIA; BETA-LACTAMASES; CEPHALOSPORINS; CLAVULANIC ACID; CLINICAL LABORATORY SERVICES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEPAL; PHENOTYPE; PUBLIC HEALTH; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; URINE;

EID: 84985024381     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-016-2192-2     Document Type: Article

References (17)

1. Wagenlehner FME, Naber KG. Treatment of bacterial urinary tract infections: present and future. Eur Urol. 2006;49:235-44.
2. Neupane S, Pant ND, Khatiwada S, Chaudhary R, Banjara MR. Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu Nepal. Antimicrob Resist Infect Control. 2016;15(5):5.
3. Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin N Am. 2006;53:379-400.
4. Taneja N, Rao P, Arora J, Dogra A. Occurrences of ESBL & AmpC β-lactamases and susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res. 2008;127:85-8.
5. Levi SB. Antibiotic resistance: consequences of inaction. Clin Infect Dis. 2001;2001(33):124-9.
6. Ashrafian F, Askari E, Kalamatizade E, Ghabouli Shahroodi MJ, Naderi-Nasab M. The frequency of extended spectrum beta lactamase in Escherichia coli and Klebsiella pneumonia. J med bacteriol. 2012;1:12-9.
7. CLSI. Performance standards for antimicrobial susceptibility testing; Twenty-First Informational Supplement. CLSI document M100-S21. Wayne PA: Clinical and Laboratory Standards Institute. 2011.
8. Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res. 2004;120:553-6.
9. Begum S, Salam MA, Begum FAN, Hassan P, Haq JA. Detection of extended spectrum β-lactamase in Pseudomonas spp. isolated from two tertiary care hospitals in Bangladesh. BMC Res Notes. 2013;6:7.
10. Baral P, Neupane S, Marasini BP, Ghimire KR, Lekhak B, Shrestha B. High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu Nepal. BMC Res Notes. 2012;5:38.
11. Awasthi TR, Pant ND, Dahal PR. Prevalence of multidrug resistant bacteria in causing community acquired urinary tract infection among the patients attending outpatient Department of Seti Zonal Hospital, Dhangadi, Nepal. Nepal J Biotechnol. 2015;3(1):55-9.
12. Jadhav S, Gandham N, Paul A, Mishra RN, Mani KR. Charactarization of multidrug resistant uropathogens E. coli (UPEC) with special reference to B2-025B-ST131-CTX-M-15 in India. J Pharm Biochem Sci. 2012;23:1-4.
13. Farrel DJ, Morrisey I, Rubies D, Robbins M, Felmingham D. A UK multicenter study of the antimicrobial susceptibility of bacterial pathogens causing UTI. J Infect. 2003;46:94-100.
14. Kahlmeter G. The ECO-SENS project: a prospective, multinational, multicenter epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J Antimicrob Chemother. 2000;46:15-22.
15. Obi CL, Tarupiwa A, Simango C. Scope of urinary pathogens isolated in the public Health Bacteriology Laboratory, Harare: antibiotic susceptibility patterns of isolates and incidence of haemolytic bacteria. Cent Afr J Med. 1996;42:244-9.
16. Collee JG, Frasier AG, Marmion BP, Simmons A. In: Collee JG, Frasier AG, Marmion BP, Simmons A, editors. Mackie and McCartney practical medical microbiology. 14th ed. New York: Churchill Livingstone; 1999. p. 361-7.
17. Svard L. Evaluation of phenotypic and genotypic extended-spectrum beta-lactamase detection methods. A project work submitted to school of biological science. Dublin: Dublin Institute of Technology; 2007. p. 48-53.